GAMBARAN POLA TERAPI OBAT PASIEN GAGAL JANTUNG DI RSUP DR. M. DJAMIL PADANG PERIODE OKTOBER-DESEMBER 2023
Description of Drug Therapy Patterns for Heart Failure Patients at RSUP Dr. M. Djamil Padang October-December 2023 period
DOI:
https://doi.org/10.30649/pst.v4i2.89Keywords:
Heart Failure Drugs , Therapy Pattern , Heart FailureAbstract
ABSTRACT
Heart failure is a complex clinical syndrome due to functional or structural ventricular dysfunction, resulting in symptoms of left ventricular dysfunction. The goal of treating heart failure is to reduce morbidity and mortality and prevent the worsening of heart disease. The purpose of this study was to describe the pattern of heart failure drug therapy at Dr. M.Jamil Padang Hospital. Data were collected retrospectively from the medical records of heart failure patients admitted to the cardiac ward. period October to December 2023 analyzed descriptively. Results: In this study, furosemide (31.29%) was followed by ramipril (21.09%) and candesartan (15.65%). The most common drug combination therapy was a combination of three drugs (32.14%), followed by a combination of two drugs (30.36%) and a combination of four drugs (22.32%). Conclusion: based on the results of the study, it can be concluded that the most widely used therapy is furosemide, ACEI, and ARB. The most common drug combination used for heart failure patients is ARB/ACEI and diuretics.
Downloads
References
Force, Mcdonagh TA, United C, Gardner RS, Force T, United C, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology ( ESC ) 2021:3599–726. https://doi.org/10.1093/eurheartj/ehab368.
McDonagh TA, Metra M, Adamo M, Baumbach A, Böhm M, Burri H, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42:3599–726. https://doi.org/10.1093/eurheartj/ehab368.
Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS. Global burden of heart failure : a comprehensive and updated review of epidemiology 2022:3272–87.
Li Y, Zhao D, Wang M, Sun J yi, Liu J, Qi Y, et al. Combined effect of menopause and cardiovascular risk factors on death and cardiovascular disease: a cohort study. BMC Cardiovasc Disord 2021;21. https://doi.org/10.1186/s12872-021-01919-5.
Witteles RM, Reddy SA. ESC Cardio-Oncology Guidelines: A Triumph—But Are We Overscreening? JACC CardioOncol 2023;5:133–6. https://doi.org/10.1016/j.jaccao.2022.10.008.
PERKI. PEDOMAN TATALAKSANA GAGAL JANTUNG. 2023.
Jurnal+Lentera+Farma+04.01-02+(09-18) n.d.
Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res 2022;118:3272–87. https://doi.org/10.1093/cvr/cvac013.
Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res 2022;118:3272–87. https://doi.org/10.1093/cvr/cvac013.
Regitz-zagrosek V, Regitz-zagrosek V. Sex and Gender Differences in Heart Failure 2020;2:157–81.
Force Mcdonagh, Theresa A, Chairperson Gardner RS, Force C, Baumbach AM, France MG, Heymans S. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology ( ESC ) 2021:1–128. https://doi.org/10.1093/eurheartj/ehab368.
Ryczkowska K, Adach W, Janikowski K, Banach M. State of the art paper Menopause and women ’ s cardiovascular health : is it really an obvious relationship ? 2023.
Regitz-Zagrosek V. Sex and Gender Differences in Heart Failure. International Journal of Heart Failure 2020;2:157–81. https://doi.org/10.36628/ijhf.2020.0004.
Wardani G, Nugraha J, Mustafa MR, Kurnijasanti R, Sudjarwo SA. Antioxidative Stress and Antiapoptosis Effect of Chitosan Nanoparticles to Protect Cardiac Cell Damage on Streptozotocin-Induced Diabetic Rat. Oxid Med Cell Longev 2022;2022. https://doi.org/10.1155/2022/3081397.
Maharani A, Sujarwoto, Praveen D, Oceandy D, Tampubolon G, Patel A. Cardiovascular disease risk factor prevalence and estimated 10-year cardiovascular risk scores in Indonesia: The SMARThealth Extend study. PLoS One 2019;14. https://doi.org/10.1371/journal.pone.0215219.
Samar R. El Khoudary, PhD, MPH, FAHA C, Brooke Aggarwal, EdD, MS F, Theresa M. Beckie, PhD F, Howard N. Hodis, MD F, Amber E. Johnson, MD, MS M, Robert D. Langer, MD, MPH F, et al. Menopause Transition and Cardiovascular 2020. https://doi.org/10.1161/CIR.0000000000000912.
Li Y, Zhao D, Wang M, Sun J, Liu J, Qi Y, et al. Combined effect of menopause and cardiovascular risk factors on death and cardiovascular disease : a cohort study. BMC Cardiovasc Disord 2021:1–13. https://doi.org/10.1186/s12872-021-01919-5.
Juwita DA, Si M. Evaluasi penggunaan obat pada pasien gagal jantung kongestif di poliklinik jantung rsup dr. m. djamilpadang 2019.
Juanli Felix Tamonob. EVALUASI PENGGUNAAN OBAT KARDIOVASKULAR ORAL PADA PASIEN GAGAL JANTUNG KONGESTIF DI INSTALASI RAWAT INAP RSUD KARANGANYAR TAHUN 2016. KARYA TULIS ILMIAH 2017.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 JOURNAL OF PHARMACY SCIENCE AND TECHNOLOGY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
